Status:
COMPLETED
Quality of Recovery of Remimazolam Versus Sevoflurane in Transurethral Bladder Resection.
Lead Sponsor:
Kangbuk Samsung Hospital
Collaborating Sponsors:
Hana Pharm Co., Ltd.
Conditions:
Quality of Recovery
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This study was designated to investigate the quality of recovery after transurethral bladder resection. Because, patients undergoing transurethral bladder resection are mostly old age, and because of ...
Eligibility Criteria
Inclusion
- adult patients aged from 19 years
- Americaln Society of Anesthesiologist's class I, II, and III
- scheduled to undergo elective transurethral bladder resection under general anesthesia
Exclusion
- refuse to participate in the study
- cannot read, or sign the consent form (e.g., iliterate, foreigner, eye disease)
- history of allergy to benzodiazepines
- decreased liver, kidney, or heart function
- pregnant women or breastfeeding patients
- history of drug or alcohol abuse
- obesity (body mass index \> 30kg/m2)
Key Trial Info
Start Date :
December 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 24 2023
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05356091
Start Date
December 2 2022
End Date
February 24 2023
Last Update
March 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eunah Cho
Seoul, South Korea, 03181